{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Breast neoplasms", "Drug resistance", "MicroRNAs", "Neoplasm metastasis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36895459", "DateCompleted": {"Year": "2023", "Month": "03", "Day": "13"}, "DateRevised": {"Year": "2023", "Month": "05", "Day": "12"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.30476/IJMS.2022.92604.2391"], "Journal": {"ISSN": "1735-3688", "JournalIssue": {"Volume": "48", "Issue": "2", "PubDate": {"Year": "2023", "Month": "Mar"}}, "Title": "Iranian journal of medical sciences", "ISOAbbreviation": "Iran J Med Sci"}, "ArticleTitle": "Multi-Drug Resistance against Second-Line Medication and MicroRNA Plasma Level in Metastatic Breast Cancer Patients.", "Pagination": {"StartPage": "146", "EndPage": "155", "MedlinePgn": "146-155"}, "Abstract": {"AbstractText": ["Circulating microRNAs (miRNAs) can help to predict the chemotherapy response in breast cancer with promising results. The aim of the present study was to investigate the relationships between the miR-199a, miR-663a, and miR-663b expression and chemotherapy response in metastatic breast cancer patients.", "This study is a case-control study performed at Yasuj University of Medical Sciences (2018-2021). The expression levels of miR-663a, miR-663b, and miR-199a in the serum of 25 patients with metastatic breast cancer versus 15 healthy individuals were determined by the real-time polymerase chain reaction method. The response to treatment was followed up in a 24-month period. All patients were treated with second-line medications. Two or more combinations of these drugs were used: gemcitabine, Navelbine<sup>\u00ae</sup>, Diphereline<sup>\u00ae</sup>, Xeloda<sup>\u00ae</sup>, letrozole, Aromasin<sup>\u00ae</sup>, and Zolena<sup>\u00ae</sup>. Statistical analyses were performed in SPSS 21.0 and GraphPad Prism 6 software. The expression levels were presented as mean\u00b1SD and analyzed by Student's <i>t</i> test.", "The results and clinicopathological features of patients were analyzed by <i>t</i> test. The statistical analysis showed that miR-663a expression was related to human epidermal growth factor receptor 2 (HER2) status and was significantly lower in the HER2<sup>+</sup> than HER2<sup>-</sup> group (P=0.027). Moreover, the expression of miR-199a and miR-663b was significantly correlated with the response to treatment, in which the expression of miR-199a was higher in the poor-response group (P=0.049), while the higher expression of miR-663b was seen in the good-response group (P=0.009).", "These findings state that the high plasma level of miR-199a and the low plasma level of miR-663b may be related to chemoresistance in patients with metastatic breast cancer."], "CopyrightInformation": "Copyright: \u00a9 Iranian Journal of Medical Sciences."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Hematology and Medical Oncology, Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Dehghani", "ForeName": "Mehdi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Students Research Committee, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Mokhtari", "ForeName": "Samira", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Abidi", "ForeName": "Hassan", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Alipoor", "ForeName": "Behnam", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Nazer Mozaffari", "ForeName": "Mohammad Amin", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Sadeghi", "ForeName": "Hossein", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Mahmoudi", "ForeName": "Reza", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Nikseresht", "ForeName": "Mohsen", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Iran", "MedlineTA": "Iran J Med Sci", "NlmUniqueID": "8104374", "ISSNLinking": "0253-0716"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "0", "NameOfSubstance": "Circulating MicroRNA"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["genetics"], "DescriptorName": "MicroRNAs"}, {"QualifierName": ["drug therapy", "genetics"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": [], "DescriptorName": "Case-Control Studies"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Circulating MicroRNA"}, {"QualifierName": [], "DescriptorName": "Drug Resistance, Multiple"}], "CoiStatement": "Dr. Mehdi Dehghani, as the Editorial Board Member, was not involved in any stage of handling this manuscript. A team of independent experts were formed by the Editorial Board to review the article without his knowledge."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333. doi: 10.3322/caac.21708.", "ArticleIdList": ["10.3322/caac.21708", "35020204"]}, {"Citation": "DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69:438\u201351. doi: 10.3322/caac.21583.", "ArticleIdList": ["10.3322/caac.21583", "31577379"]}, {"Citation": "Danaei M, Haghdoost A, Momeni M. An epidemiological review of common cancers in Iran; a review article. Iranian Journal of Blood and Cancer. 2019;11:77\u201384."}, {"Citation": "Fang C, Wang FB, Li Y, Zeng XT. Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients. Biomed Pharmacother. 2016;84:1189\u201393. doi: 10.1016/j.biopha.2016.10.006.", "ArticleIdList": ["10.1016/j.biopha.2016.10.006", "27788476"]}, {"Citation": "McGuire A, Brown JA, Kerin MJ.  Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.  Cancer Metastasis Rev.  2015;34:145\u201355. doi: 10.1007/s10555-015-9551-7. [  PMC Free Article\n]", "ArticleIdList": ["10.1007/s10555-015-9551-7", "PMC4368851", "25721950"]}, {"Citation": "Kurland BF, Wiggins JR, Coche A, Fontan C, Bouvet Y, Webner P, et al.  Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16alpha-18F-Fluoro-17beta-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications.  Oncologist.  2020;25:835\u201344. doi: 10.1634/theoncologist.2019-0967. [  PMC Free Article\n]", "ArticleIdList": ["10.1634/theoncologist.2019-0967", "PMC7543360", "32374053"]}, {"Citation": "Zimmer AS, Van Swearingen AED, Anders CK.  HER2-positive breast cancer brain metastasis: A new and exciting landscape.  Cancer Rep (Hoboken)  2022;5:e1274. doi: 10.1002/cnr2.1274. [  PMC Free Article\n]", "ArticleIdList": ["10.1002/cnr2.1274", "PMC9124511", "32881421"]}, {"Citation": "Deblois G, Tonekaboni SAM, Grillo G, Martinez C, Kao YI, Tai F, et al. Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer. Cancer Discov. 2020;10:1312\u201329. doi: 10.1158/2159-8290.CD-19-1493.", "ArticleIdList": ["10.1158/2159-8290.CD-19-1493", "32546577"]}, {"Citation": "Tecza K, Pamula-Pilat J, Lanuszewska J, Butkiewicz D, Grzybowska E.  Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.  Oncotarget.  2018;9:9114\u201336. doi: 10.18632/oncotarget.24148. [  PMC Free Article\n]", "ArticleIdList": ["10.18632/oncotarget.24148", "PMC5823653", "29507678"]}, {"Citation": "Inoue K, Fry EA.  Novel Molecular Markers for Breast Cancer.  Biomark Cancer.  2016;8:25\u201342. doi: 10.4137/BIC.S38394. [  PMC Free Article\n]", "ArticleIdList": ["10.4137/BIC.S38394", "PMC4790586", "26997872"]}, {"Citation": "Gao M, Miao L, Liu M, Li C, Yu C, Yan H, et al.  miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1.  Oncotarget.  2016;7:59714\u201326. doi: 10.18632/oncotarget.10845. [  PMC Free Article\n]", "ArticleIdList": ["10.18632/oncotarget.10845", "PMC5312343", "27487127"]}, {"Citation": "Hu H, Li S, Cui X, Lv X, Jiao Y, Yu F, et al.  The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2)  J Biol Chem.  2013;288:10973\u201385. doi: 10.1074/jbc.M112.434340. [  PMC Free Article\n]", "ArticleIdList": ["10.1074/jbc.M112.434340", "PMC3630848", "23436656"]}, {"Citation": "Mulrane L, McGee SF, Gallagher WM, O\u2019Connor DP. miRNA dysregulation in breast cancer. Cancer Res. 2013;73:6554\u201362. doi: 10.1158/0008-5472.CAN-13-1841.", "ArticleIdList": ["10.1158/0008-5472.CAN-13-1841", "24204025"]}, {"Citation": "Wang Z, Wang N, Liu P, Chen Q, Situ H, Xie T, et al.  MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin.  Oncotarget.  2014;5:7013\u201326. doi: 10.18632/oncotarget.2192. [  PMC Free Article\n]", "ArticleIdList": ["10.18632/oncotarget.2192", "PMC4196180", "25026296"]}, {"Citation": "Deblois G, Tonekaboni SAM, Grillo G, Martinez C, Kao YI, Tai F, et al. Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer. Cancer Discov. 2020;10:1312\u201329. doi: 10.1158/2159-8290.CD-19-1493.", "ArticleIdList": ["10.1158/2159-8290.CD-19-1493", "32546577"]}, {"Citation": "Kim YK.  Extracellular microRNAs as Biomarkers in Human Disease.  Chonnam Med J.  2015;51:51\u20137. doi: 10.4068/cmj.2015.51.2.51. [  PMC Free Article\n]", "ArticleIdList": ["10.4068/cmj.2015.51.2.51", "PMC4543150", "26306299"]}, {"Citation": "Oom AL, Humphries BA, Yang C.  MicroRNAs: novel players in cancer diagnosis and therapies.  Biomed Res Int.  2014;2014:959461. doi: 10.1155/2014/959461. [  PMC Free Article\n]", "ArticleIdList": ["10.1155/2014/959461", "PMC4101974", "25101302"]}, {"Citation": "Chen J, Shin VY, Siu MT, Ho JC, Cheuk I, Kwong A.  miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.  BMC Cancer.  2016;16:887. doi: 10.1186/s12885-016-2916-7. [  PMC Free Article\n]", "ArticleIdList": ["10.1186/s12885-016-2916-7", "PMC5109692", "27842518"]}, {"Citation": "Sadakierska-Chudy A.  MicroRNAs: Diverse Mechanisms of Action and Their Potential Applications as Cancer Epi-Therapeutics.  Biomolecules.  2020;10 doi: 10.3390/biom10091285. [  PMC Free Article\n]", "ArticleIdList": ["10.3390/biom10091285", "PMC7565521", "32906681"]}, {"Citation": "Feng J, Wang X, Zhu W, Chen S, Feng C. MicroRNA-630 Suppresses Epithelial-to-Mesenchymal Transition by Regulating FoxM1 in Gastric Cancer Cells. Biochemistry (Mosc) 2017;82:707\u201314. doi: 10.1134/S0006297917060074.", "ArticleIdList": ["10.1134/S0006297917060074", "28601080"]}, {"Citation": "Li Y, Shan Z, Liu C, Yang D, Wu J, Men C, et al. MicroRNA-294 Promotes Cellular Proliferation and Motility through the PI3K/AKT and JAK/STAT Pathways by Upregulation of NRAS in Bladder Cancer. Biochemistry (Mosc) 2017;82:474\u201382. doi: 10.1134/S0006297917040095.", "ArticleIdList": ["10.1134/S0006297917040095", "28371605"]}, {"Citation": "Xu X, Zhang Y, Jasper J, Lykken E, Alexander PB, Markowitz GJ, et al.  MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.  Oncotarget.  2016;7:20381\u201394. doi: 10.18632/oncotarget.7953. [  PMC Free Article\n]", "ArticleIdList": ["10.18632/oncotarget.7953", "PMC4991462", "26967387"]}, {"Citation": "Jayaraj R, Nayagam SG, Kar A, Sathyakumar S, Mohammed H, Smiti M, et al.  Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis.  Cells.  2019;8 doi: 10.3390/cells8101250. [  PMC Free Article\n]", "ArticleIdList": ["10.3390/cells8101250", "PMC6830093", "31615089"]}, {"Citation": "Zhang HY, Li CH, Wang XC, Luo YQ, Cao XD, Chen JJ. MiR-199 inhibits EMT and invasion of hepatoma cells through inhibition of Snail expression. Eur Rev Med Pharmacol Sci. 2019;23:7884\u201391. doi: 10.26355/eurrev_201909_18998.", "ArticleIdList": ["10.26355/eurrev_201909_18998", "31599450"]}, {"Citation": "Michaille JJ, Piurowski V, Rigot B, Kelani H, Fortman EC, Tili E.  MiR-663, a MicroRNA Linked with Inflammation and Cancer That Is under the Influence of Resveratrol.  Medicines (Basel)  2018;5 doi: 10.3390/medicines5030074. [  PMC Free Article\n]", "ArticleIdList": ["10.3390/medicines5030074", "PMC6163211", "29987196"]}, {"Citation": "Jung EJ, Santarpia L, Kim J, Esteva FJ, Moretti E, Buzdar AU, et al.  Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients.  Cancer.  2012;118:2603\u201314. doi: 10.1002/cncr.26565. [  PMC Free Article\n]", "ArticleIdList": ["10.1002/cncr.26565", "PMC3864019", "22370716"]}, {"Citation": "Ding L, Gu H, Xiong X, Ao H, Cao J, Lin W, et al.  MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance and Applications in Human Triple-Negative Breast Cancer.  Cells.  2019;8 doi: 10.3390/cells8121492. [  PMC Free Article\n]", "ArticleIdList": ["10.3390/cells8121492", "PMC6953059", "31766744"]}, {"Citation": "Shaffi SK, Galas D, Etheridge A, Argyropoulos C.  Role of MicroRNAs in Renal Parenchymal Diseases-A New Dimension.  Int J Mol Sci.  2018;19 doi: 10.3390/ijms19061797. [  PMC Free Article\n]", "ArticleIdList": ["10.3390/ijms19061797", "PMC6032378", "29914215"]}, {"Citation": "Chen E, Xu X, Liu R, Liu T.  Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.  Biomed Res Int.  2018;2018:6784607. doi: 10.1155/2018/6784607. [  PMC Free Article\n]", "ArticleIdList": ["10.1155/2018/6784607", "PMC5987324", "29951542"]}, {"Citation": "Svoronos AA, Engelman DM, Slack FJ.  OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.  Cancer Res.  2016;76:3666\u201370. doi: 10.1158/0008-5472.CAN-16-0359. [  PMC Free Article\n]", "ArticleIdList": ["10.1158/0008-5472.CAN-16-0359", "PMC4930690", "27325641"]}, {"Citation": "Davey MG, Lowery AJ, Miller N, Kerin MJ.  MicroRNA Expression Profiles and Breast Cancer Chemotherapy.  Int J Mol Sci.  2021;22 doi: 10.3390/ijms221910812. [  PMC Free Article\n]", "ArticleIdList": ["10.3390/ijms221910812", "PMC8509379", "34639152"]}, {"Citation": "Mussnich P, Rosa R, Bianco R, Fusco A, D\u2019Angelo D. MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1. Expert Opin Ther Targets. 2015;19:1017\u201326. doi: 10.1517/14728222.2015.1057569.", "ArticleIdList": ["10.1517/14728222.2015.1057569", "26107137"]}, {"Citation": "Xu X, Zhang L, He X, Zhang P, Sun C, Xu X, et al. TGF-beta plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis. Biochem Biophys Res Commun. 2018;502:160\u20135. doi: 10.1016/j.bbrc.2018.05.139.", "ArticleIdList": ["10.1016/j.bbrc.2018.05.139", "29792857"]}, {"Citation": "Asghariazar V, Sakhinia E, Mansoori B, Mohammadi A, Baradaran B. Tumor suppressor microRNAs in lung cancer: An insight to signaling pathways and drug resistance. J Cell Biochem. 2019;120:19274\u201389. doi: 10.1002/jcb.29295.", "ArticleIdList": ["10.1002/jcb.29295", "31364210"]}, {"Citation": "Nakano M, Kikushige Y, Miyawaki K, Kunisaki Y, Mizuno S, Takenaka K, et al. Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer. Oncogene. 2019;38:780\u201393. doi: 10.1038/s41388-018-0480-0.", "ArticleIdList": ["10.1038/s41388-018-0480-0", "30181548"]}, {"Citation": "Zhao M, Mishra L, Deng CX.  The role of TGF-beta/SMAD4 signaling in cancer.  Int J Biol Sci.  2018;14:111\u201323. doi: 10.7150/ijbs.23230. [  PMC Free Article\n]", "ArticleIdList": ["10.7150/ijbs.23230", "PMC5821033", "29483830"]}, {"Citation": "Batlle E, Massague J.  Transforming Growth Factor-beta Signaling in Immunity and Cancer.  Immunity.  2019;50:924\u201340. doi: 10.1016/j.immuni.2019.03.024. [  PMC Free Article\n]", "ArticleIdList": ["10.1016/j.immuni.2019.03.024", "PMC7507121", "30995507"]}, {"Citation": "Tripathi V, Shin JH, Stuelten CH, Zhang YE.  TGF-beta-induced alternative splicing of TAK1 promotes EMT and drug resistance.  Oncogene.  2019;38:3185\u2013200. doi: 10.1038/s41388-018-0655-8. [  PMC Free Article\n]", "ArticleIdList": ["10.1038/s41388-018-0655-8", "PMC6486402", "30626936"]}, {"Citation": "Hahne JC, Valeri N.  Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.  Front Oncol.  2018;8:226. doi: 10.3389/fonc.2018.00226. [  PMC Free Article\n]", "ArticleIdList": ["10.3389/fonc.2018.00226", "PMC6015885", "29967761"]}, {"Citation": "Li S, Bi T, Wang R, Gao X, Zhou J. Circulating MiR-663 as a novel biomarker for chemo-resistance in breast cancer of neoadjuvant chemotherapy. Int J Clin Exp Med. 2016;9:4002\u20138."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "9", "Day": "4"}, {"Year": "2021", "Month": "12", "Day": "26"}, {"Year": "2022", "Month": "3", "Day": "18"}, {"Year": "2023", "Month": "3", "Day": "10", "Hour": "2", "Minute": "27"}, {"Year": "2023", "Month": "3", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36895459", "PMC9989244", "10.30476/IJMS.2022.92604.2391", "IJMS-48-2"]}}], "PubmedBookArticle": []}